資源描述:
《基于胃陰學(xué)說(shuō)治療慢性胃炎的臨床研究》由會(huì)員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在學(xué)術(shù)論文-天天文庫(kù)。
1、提要目的:通過(guò)文獻(xiàn)及臨床研究,探討胃陰學(xué)說(shuō)在治療慢性胃炎中的運(yùn)用,從而為養(yǎng)胃陰法治療慢性胃炎提供理論基礎(chǔ);在辨證加減基礎(chǔ)上結(jié)合自擬養(yǎng)胃方治療慢性胃炎,觀察其臨床療效,闡明本病的病因病機(jī),以進(jìn)一步提高臨床療效。方法:收集山東省中醫(yī)院消化內(nèi)鏡診療科及脾胃科門(mén)診及病房的慢性胃炎病例60例,隨機(jī)分為治療組30例,對(duì)照組30例。治療組:給予以自擬養(yǎng)胃方為基礎(chǔ)方的中藥湯劑口服,每日一劑,分兩次服用,再配合雷貝拉唑腸溶膠囊(濟(jì)諾)口服,每次20mg,每日1次,枸櫞酸莫沙比利片(快力),每次5mg,每日3次,總療程為1個(gè)月。對(duì)照組:給予雷貝拉唑腸溶膠囊口服,每次20mg,每日1次,枸櫞酸莫沙比利片(快力),
2、每次5mg,每日3次,總療程為1個(gè)月。兩組在治療期間,均停用其它治療胃病的藥物。觀察1個(gè)療程,比較治療前、治療后癥狀的改善情況,分析臨床療效。結(jié)果:在癥狀改善方面,治療組及對(duì)照組均能改善胃痛、痞滿、噯氣反酸、燒心、嘈雜、納少、乏力癥狀(P<0.O5),除在改善嘈雜癥狀上治療組與對(duì)照組無(wú)顯著差異(P>0.05)外,其余癥狀的改善情況,治療組均明顯優(yōu)于對(duì)照組(P<0.05),治療組總有效率為93.33%,對(duì)照組總有效率為80.00%,故治療組在治療慢性胃炎改善其臨床癥狀上明顯優(yōu)于對(duì)照組(P<0.05)。結(jié)論:正確運(yùn)用胃陰學(xué)說(shuō)指導(dǎo)治療慢性胃炎可取得較好的臨床療效,基于胃陰學(xué)說(shuō)的自擬養(yǎng)胃方在改善慢性
3、胃炎臨床癥狀上明顯優(yōu)于單純應(yīng)用西藥的對(duì)照組。關(guān)鍵詞慢性胃炎;胃陰學(xué)說(shuō);養(yǎng)胃陰法;臨床療效TheClinicalStudyofTreatingChronicGastritisbasedonWeiyinTheorySpeciality:InternalMedicineofTraditionalChinesemedicineAuthor:KangNanTutor:Prof.CaoZhiqunAbstractPurpose:Basedonliteraturematerialsandclinicalresearches,studytheapplicationofweiyintheoryintreati
4、ngchronicgastritis,inordertoprovidetheoreticalbasisofusingyangweiyinmethodtotreatchronicgastritis.Modifyziniyangweifangtotreatchronicgastritis,observeitsclinicaleffect,clarifytheetiologyandpathogenesis,inordertoimprovetheclinicaleffect.Method:Collect60inpatientsandoutpatientsofchronicgastritisfromS
5、handongTroditionalChineseMedicineHospital,casesarerandomlydividedintotwogroups,30casesintreatmentgroupand30casesincontrolgroup.Treatmentgroup:treatmentwithziniyangweifang,2timesaday,200mlpoatime,rabeprazolecapsule20mgatime,1timeaday,MosaprideCitrateTablets5mgatime,3timesaday.controlgroup:treatmentw
6、ithrabeprazolecapsule20mgatime,1timeaday,MosaprideCitrateTablets5mgatime,3timesaday.1monthasacourse.Duringthetreatingcourse,stopalltheothermedicineswhichcantreatchronicgastritis.Twogroupswerecomparedwithbythesymptomsbeforeandafterthetreatment.Conclusion:Comparingtheeffectofimprovingclinicalsymptoms
7、withtwogroupssuchasstomachpain,fullnessinepigastria,belching,lossofappetiteandfatigue,thereissignificantdifferencebetweenthetreatmentandcontrolgroup(P<0.O5),butthereisnosignificantdifferencesinthenoisysympt